AIM2 and colorectal carcinoma: Studies on Aim2-/- mice have shown a higher incidence of colitis-associated CRC compared to Asc-/-mice with defective inflammasomes, suggesting that AIM2's impact on CRC is not dependent on inflammasome activation.